• Skip to main content
  • Skip to primary sidebar
Transfusion News
  • About Us
  • Topics
    • Adverse Events (non-infectious)
    • Blood Donation
    • Cell Therapy
    • Coagulation & Plasma Transfusion
    • Platelet Transfusion
    • Policy and Guidelines
    • Quality Control and Regulatory
    • RBC Transfusion
    • Serology/Genotyping
    • Special Transfusion Situations
    • Transfusion Transmitted Infections
  • Continuing Education
  • Archives
  • Podcasts
  • Question of the Day
  • Search
  • Subscribe to Email Alerts
  • Follow us on
  • Search
  • Subscribe to Email Alerts

Cryopreserved Platelets are Hemostatically Functional in Vitro

March 23, 2016

Activated platelet, SEMInventory and storage of cryopreserved platelets (CPP) would be simple in comparison to platelets that are normally stored at room temperature for up to 7 days. Previous in vivo studies have suggested that CPPs are safe and hemostatically effective. However, in vitro studies have provided discrepant results. In order to investigate the in vitro properties of CPP, fresh whole blood was collected from 8 donors. In this 4-arm study, hemostatic properties of whole blood were compared to platelet-depleted whole blood, and whole blood with restored platelets (cryopreserved or stored in standard liquid for 5 days). Results suggest that CPP-restored whole blood has the fastest clotting time, can form stable platelet clots, and can effectively support the conversion of prothrombin to thrombin and fibrin without a risk of thrombosis. Further research into the safety of CPP in vivo is necessary as CPPs may be helpful in some clinical settings.

Reference

1. Cid J, Escolar G, Galan A, Lopez-Vilchez I, Molina P, Diaz-Ricart M, Lozano M, Dumont LJ. In vitro evaluation of the hemostatic effectiveness of cryopreserved platelets. Transfusion 2016;56: 580-6.

Filed Under

  • CME
  • News
  • Platelet Transfusion

Recommended

  • Intracellular RBC Antigens Can Enhance RBC Alloimmunization in Mice

  • Cryopreserved Platelets Are Safe and Prevent Bleeding

  • Platelet-Rich Plasma Injections Do Not Improve Ankle Osteoarthritis

Show Comments

Comments on this article are closed.

Get the latest news. Subscribe to our mailing list. Sign Up

Primary Sidebar

Latest News

  • Plasma Equivalent to Clotting Factor Concentrates for Initial Resuscitation of Patients with Severe Trauma

  • Personalized Prediction Model of Prophylactic Platelet Transfusions for Preterm Infants

  • Caffeine in Donor Blood Reduces Quality of Stored RBCs

  • Ferritin Levels Needed to Assess Hemoglobin Recovery after Blood Donation

    Question of the Day

    Copyright © 2025 John Wiley & Sons, Inc. All Rights Reserved.
    Privacy Policy

    Association for the Advancement of Blood and Biotherapies Wiley